[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.5487/TR.2010.26.4.245

Epithelial-mesenchymal Transition and Cell Invasion

Son, Hwa-Jin (College of Pharmacy, Duksung Women's University)
Moon, Aree (College of Pharmacy, Duksung Women's University)

Publication Information

Toxicological Research / v.26, no.4, 2010 , pp. 245-252 More about this Journal

Abstract

Epithelial-mesenchymal transition (EMT) is a complex process in which epithelial cells acquire the characteristics of invasive mesenchymal cells. EMT has been implicated in cancer progression and metastasis as well as the formation of many tissues and organs during development. Epithelial cells undergoing EMT lose cell-cell adhesion structures and polarity, and rearrange their cytoskeletons. Several oncogenic pathways such as transforming growth factor (TGF)- $\beta$ , Wnt, and Notch signaling pathways, have been shown to induce EMT. These pathways have activated transcription factors including Snail, Slug, and the ZEB family which work as transcriptional repressors of E-cadherin, thereby making epithelial cells motile and resistant to apoptosis. Mounting evidence shows that EMT is associated with cell invasion and tumor progression. In this review, we summarize the characteristic features of EMT, pathways leading to EMT, and the role of EMT in cell invasion. Three topics are addressed in this review: (1) Definition of EMT, (2) Signaling pathways leading to EMT, (3) Role of EMT in cell invasion. Understanding the role of EMT in cell invasion will provide valuable information for establishing strategies to develop anti-metastatic therapeutics which modulate malignant cellular processes mediated by EMT.

Keywords

EMT; cell invasion; TGF- $\beta$ ; Wnt; Notch;

Citations & Related Records

Reference

1	Xu, J., Lamouille, S. and Derynck, R. (2009). TGF-beta-induced epithelial to mesenchymal transition. Cell Res., 19, 156-172. DOI ScienceOn
2	Yee, D.S., Tang, Y., Li, X., Liu, Z., Guo, Y., Ghaffar, S., McQueen, P., Atreya, D., Xie, J., Simoneau, A.R., Hoang, B.H. and Zi, X. (2010). The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition. Mol. Cancer, 9, 162. DOI ScienceOn
3	Yi, J.Y., Shin, I. and Arteaga, C.L. (2005). Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase. J. Biol. Chem., 280, 10870-10876. DOI ScienceOn
4	Yook, J.I., Li, X.Y., Ota, I., Fearon, E.R. and Weiss, S.J. (2005). Wnt-dependent regulation of the E-cadherin repressor snail. J. Biol. Chem., 280, 11740-11748. DOI ScienceOn
5	Yu, L., Hébert, M.C. and Zhang, Y.E. (2002). TGF-beta receptoractivated p38 MAP kinase mediates Smad-independent TGFbeta responses. EMBO J., 21, 3749-3759. DOI ScienceOn
6	Zavadil, J. and Bottinger, E.P. (2005). TGF-beta and epithelial-tomesenchymal transitions. Oncogene, 24, 5764-5774. DOI ScienceOn
7	Zavadil, J., Cermak, L., Soto-Nieves, N. and Bottinger, E.P. (2004). Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J., 23, 1155-1165. DOI ScienceOn
8	Zavadil, J., Narasimhan, M., Blumenberg, M. and Schneider, R.J. (2007). Transforming growth factor-beta and microRNA: mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs, 185, 157-161. DOI ScienceOn
9	Timmerman, L.A., Grego-Bessa, J., Raya, A., Bertran, E., Perez-Pomares, J.M., Diez, J., Aranda, S., Palomo, S., McCormick, F., Izpisua-Belmonte, J.C. and de la Pompa, J.L. (2004). Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev., 18, 99-115. DOI ScienceOn
10	Trelstad, R.L., Hay, E.D. and Revel, J.D. (1967). Cell contact during early morphogenesis in the chick embryo. Dev. Biol., 16, 78-106. DOI ScienceOn
11	Saika, S., Kono-Saika, S., Ohnishi, Y., Sato, M., Muragaki, Y., Ooshima, A., Flanders, K.C., Yoo, J., Anzano, M., Liu, C.Y., Kao, W.W. and Roberts, A.B. (2004). Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury. Am. J. Pathol., 164, 651-663. DOI ScienceOn
12	Santibanez, J.F. (2006). JNK mediates TGF-beta1-induced epithelial mesenchymal transdifferentiation of mouse transformed keratinocytes. FEBS Lett., 580, 5385-5391. DOI ScienceOn
13	Sarbassove, D.D., Ali, S.M., and Sabatini, D.M. (2005). Growing roles for the mTOR pathway. Curr. Opin. Cell Biol., 17, 596-603. DOI ScienceOn
14	Sato, M., Muragaki, Y., Saika, S., Roberts, A.B. and Ooshima, A. (2003). Targeted disruption of TGF- $\beta$ 1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J. Clin. Invest., 112, 1486-1494. DOI
15	Schilling, S.H., Hjelemeland, A.B., Rich, J.N. and Wang, X.F. (2008). TGF- $\beta$ Family (eds. Derynck, R., and Miyazono, K.). Cold Spring Harbor Laboratory Pres, New York, pp. 45-78.
16	Snoek-van Beurden, P.A. and Von den Hoff, J.W. (2005). Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. Biotechniques, 38, 73-83. DOI
17	Oft, M., Heider, K.H. and Beug, H. (1998). TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol., 8, 1243-1252. DOI ScienceOn
18	Nawshad, A., Medici, D., Liu, C.C. and Hay, E.D. (2007). TGFbeta3 inhibits E-cadherin gene expression in palate medialedge epithelial cells through a Smad2-Smad4-LEF1 transcription complex. J. Cell. Sci., 120, 1646-1653. DOI ScienceOn
19	Nishihara, A., Hanai, J.I., Okamoto, N., Yanagisawa, J., Kato, S., Miyazono, K. and Kawabata, M. (1998). Role of p300, a transcriptional coactivator, in signalling of TGF-beta. Genes Cells, 3, 613-623. DOI ScienceOn
20	Noel, A., Boulay, A., Kebers, F., Kannan, R., Hajitou, A., Calberg-Bacq, C.M., Basset, P., Rio, M.C. and Foidart, J.M. (2000). Demonstration in vivo that stromelysin-3 functions through its proteolytic activity. Oncogene,19, 1605-1612. DOI
21	Lehmann, K., Janda, E., Pierreux, C.E., Rytömaa, M., Schulze, A., McMahon, M., Hill, C.S., Beug, H. and Downward, J. (2000). Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev., 14, 2610-2622. DOI
22	Lewis-Tuffin, L.J., Rodriguez, F., Giannini, C., Scheithauer, B., Necela, B.M., Sarkaria, J.N. and Anastasiadis, P.Z. (2010). Misregulated e-cadherin expression associated with an aggressive brain tumor phenotype. PLoS One., 5, e13665. DOI ScienceOn
23	Lien, S.C., Usami, S., Chien, S. and Chiu, J.J. (2006). Phosphatidylinositol 3-kinase/Akt pathway is involved in transforming growth factor-beta1-induced phenotypic modulation of 10T1/2 cells to smooth muscle cells. Cell Signal, 18, 1270-1278. DOI ScienceOn
24	Valcourt, U., Kowanetz, M., Niimi, H., Heldin, C.H. and Moustakas, A. (2005). TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol. Biol. Cell, 16, 1987-2002. DOI ScienceOn
25	Zhou, B.P., Deng, J., Xia, W., Xu, J., Li, Y.M., Gunduz, M. and Hung, M.C. (2004). Dual regulation of Snail by GSK-3betamediated phosphorylation in control of epithelial-mesenchymal transition. Nat. Cell Biol., 6, 931-940. DOI ScienceOn
26	Trimboli, A.J., Fukino, K., de Bruin, A., Wei, G., Shen, L., Tanner, S.M., Creasap, N., Rosol, T.J., Robinson, M.L., Eng, C., Ostrowski, M.C. and Leone, G. (2008). Direct evidence for epithelial- mesenchymal transitions in breast cancer. Cancer Res., 68, 937-945. DOI ScienceOn
27	Uttamsingh, S., Bao, X., Nguyen, K.T., Bhanot, M., Gong, J., Chan, J.L., Liu, F., Chu, T.T. and Wang, L.H. (2008). Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene, 27, 2626-2634. DOI ScienceOn
28	Voulgari, A. and Pintzas, A. (2009). Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim. Biophys. Acta., 1796, 75-90.
29	Vuoriluoto, K., Haugen, H., Kiviluoto, S., Mpindi, J.P., Nevo, J., Gjerdrum, C., Tiron, C., Lorens, J.B. and Ivaska, J. (2010). Vimentin regulates EMT induction by Slug and oncogenic HRas and migration by governing Axl expression in breast cancer. Oncogene, Epub ahead of print.
30	Wang, Z., Banerjee, S., Li, Y., Rahman, K.M., Zhang, Y. and Sarkar, F.H. (2006). Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res., 66, 2778-2784. DOI ScienceOn
31	Wick, W., Platten, M. and Weller, M. (2001). Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. J. Neurooncol., 53, 177-185. DOI ScienceOn
32	Perez-Moreno, M., Jamora, C. and Fuchs, E. (2003). Sticky business: orchestrating cellular signals at adherens junctions. Cell, 112, 535-548. DOI ScienceOn
33	Somiari, S.B., Somiari, R.I., Heckman, C.M., Olsen, C.H., Jordan, R.M., Russell, S.J. and Shriver, C.D. (2006). Circulating MMP2 and MMP9 in breast cancer -- potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int. J. Cancer, 119, 1403-1411. DOI ScienceOn
34	Song, H., Ki, S.H., Kim, S.G. and Moon, A. (2006). Activating transcription factor 2 mediates matrix metalloproteinase-2 transcriptional activation induced by p38 in breast epithelial cells. Cancer Res., 66, 10487-10496. DOI ScienceOn
35	Peinado, H., Olmeda, D. and Cano, A. (2007). Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nature Reviews Cancer, 7, 415-428. DOI ScienceOn
36	Piek, E., Moustakas, A., Kurisaki, A., Heldin, C.H. and Ten Dijke, P. (1999). TGF-β type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J. Cell Sci., 112, 4557-4568.
37	Platten, M., Wick, W. and Weller, M. (2001). Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape. Microsc. Res. Tech., 52, 401-410. DOI ScienceOn
38	Pon, Y.L., Zhou, H.Y., Cheung, A.N., Ngan, H.Y. and Wong, A.S. (2008). p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells. Cancer Res., 68, 6524-6532. DOI ScienceOn
39	Radisky, E.S. and Radisky, D.C. (2010). Matrix metalloproteinaseinduced epithelial-mesenchymal transition in breast cancer. J. Mammary Gland Biol. Neoplasia., 15, 201-212. DOI ScienceOn
40	Lin, C.C., Chiang, L.L., Lin, C.H., Shih, C.H., Liao, Y.T., Hsu, M.J. and Chen, B.C. (2007). Transforming growth factor-beta1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways in human lung epithelial cells. Eur. J. Pharmacol., 560, 101-109. DOI ScienceOn
41	Liu, D., Nakano, J., Ishikawa, S., Yokomise, H., Ueno, M., Kadota, K., Urushihara, M. and Huang, C.L. (2007). Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer. Lung Cancer, 58, 384-391. DOI ScienceOn
42	Massague, J. and Chen, Y.G. (2000). Controlling TGF-beta signaling. Genes Dev., 14, 627-644.
43	McConkey, D.J., Choi, W., Marquis, L., Martin, F., Williams, M.B., Shah, J., Svatek, R., Das, A., Adam, L., Kamat, A., Siefker-Radtke, A. and Dinney, C. (2009). Role of epithelial-tomesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev., 28, 335-344. DOI
44	McGuire, J.K., Li, Q. and Parks, W.C. (2003). Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. Am. J. Pathol., 162, 1831-1843. DOI ScienceOn
45	Ju, W., Ogawa, A., Heyer, J., Nierhof, D., Yu, L., Kucherlapati, R., Shafritz, D.A. and Böttinger, E.P. (2006). Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol. Cell. Biol., 26, 654-667. DOI ScienceOn
46	Kalluri, R. and Neilson, E.G. (2003). Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest., 112, 1776-1784. DOI
47	Kang, Y. and Massague, J. (2004). Epithelial-mesenchymal transitions: twist in development and metastasis. Cell, 118, 277-279. DOI ScienceOn
48	Grande, M., Franzen, A., Karlsson, J.O., Ericson, L.E., Heldin, N.E. and Nilsson, M. (2002). Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J. Cell. Sci., 115, 4227-4236. DOI
49	Ghoul, A., Serova, M., Astorgues-Xerri, L., Bieche, I., Bousquet, G., Varna, M., Vidaud, M., Phillips, E., Weill, S., Benhadji, K.A., Lokiec, F., Cvitkovic, E., Faivre, S. and Raymond, E. (2009). Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells. Cancer Res., 69, 4260-4269. DOI ScienceOn
50	Gotzmann, J., Mikula, M., Eger, A., Schulte-Hermann, R., Foisner, R., Beug, H. and Mikulits, W. (2004). Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat. Res., 566, 9-20. DOI ScienceOn
51	Greenburg, G. and Hay, E.D. (1982). Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J. Cell. Biol., 95, 333-339. DOI
52	Greenburg, G. and Hay, E.D. (1986). Cytodifferentiation and tissue phenotype change during transformation of embryonic lens epithelium to mesenchyme-like cells in vitro. Dev. Biol., 115, 363-379. DOI ScienceOn
53	Grunert, S., Jechlinger, M. and Beug, H. (2003). Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell. Biol., 4, 657-665. DOI ScienceOn
54	Brabletz, T., Jung, A., Reu, S., Porzner, M., Hlubek, F., Kunz-Schughart, L.A., Knuechel, R. and Kirchner, T. (2001). Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc. Natl. Acad. Sci., 98, 10356-10361. DOI ScienceOn
55	Takkunen, M., Grenman, R., Hukkanen, M., Korhonen, M., García de Herreros, A. and Virtanen, I. (2006). Snail-dependent and - independent epithelial-mesenchymal transition in oral squamous carcinoma cells. J. Histochem. Cytochem., 54, 1263-1275. DOI ScienceOn
56	Xie, L., Law, B.K., Chytil, A.M., Brown, K.A., Aakre, M.E. and Moses, H.L. (2004). Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia, 6, 603-610. DOI ScienceOn
57	Song, W., Jackson, K. and McGuire, P.G. (2000). Degradation of type IV collagen by matrix metalloproteinases is an important step in the epithelial-mesenchymal transformation of the endocardial cushions. Dev. Biol., 227, 606-617. DOI ScienceOn
58	Taki, M., Kamata, N., Yokoyama, K., Fujimoto, R., Tsutsumi, S. and Nagayama, M. (2003). Down-regulation of Wnt-4 and upregulation of Wnt-5a expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Cancer Sci., 94, 593-597. DOI ScienceOn
59	Tavares, A.L., Mercado-Pimentel, M.E., Runyan, R.B. and Kitten, G.T. (2006). TGF- $\beta$ -mediated RhoA expression is necessary for epithelial-mesenchymal transition in the embryonic chick heart. Dev. Dyn., 235, 1589-1598. DOI ScienceOn
60	Thiery, J.P. (2002). Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer, 2, 442-454. DOI ScienceOn
61	Thiery, J.P. (2003). Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell. Biol., 15, 740-746. DOI ScienceOn
62	Thiery, J.P. and Morgan, M. (2004). Breast cancer progression with a Twist. Nat. Med., 10, 777-778. DOI ScienceOn
63	Micalizzi, D.S., Farabaugh, S.M. and Ford, H.L. (2010). Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J. Mammary Gland Biol. Neoplasia, 15, 117-134. DOI
64	Radisky, D.C., Levy, D.D., Littlepage, L.E., Liu, H., Nelson, C.M., Fata, J.E., Leake, D., Godden, E.L., Albertson, D.G., Nieto, M.A., Werb, Z. and Bissell, M.J. (2005). Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature, 436, 123-127. DOI ScienceOn
65	Reiss, M. and Barcellos-Hoff, M.H. (1997). Transforming growth factor-beta in breast cancer: a working hypothesis. Breast Cancer Res. Treat., 45, 81-95. DOI ScienceOn
66	Roger, L., Jullien, L., Gire, V. and Roux, P. (2010). Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells. J. Cell Sci., 123, 1295-1305. DOI ScienceOn
67	Morgia, G., Falsaperla, M., Malaponte, G., Madonia, M., Indelicato, M., Travali, S. and Mazzarino, M.C. (2005). Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer. Urol Res., 33, 44-50. DOI
68	Moustakas, A. and Heldin, C.H. (2005). Non-Smad TGF-beta signals. J. Cell Sci., 118, 3573-3584. DOI ScienceOn
69	Moustakas, A. and Heldin, C.H. (2007). Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and caner progression. Cancer Sci., 98, 1512-1520. DOI ScienceOn
70	Nawshad, A., Lagamba, D., Polad, A. and Hay, E.D. (2005). Transforming growth factor-beta signaling during epithelialmesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs, 179, 11-23. DOI ScienceOn
71	Lamouille, S. and Derynck, R. (2007). Cell size and invasion in TGF- $\beta$ -induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J. Cell Biol., 178, 437-451. DOI ScienceOn
72	Kim, E.S., Kim, M.S. and Moon, A. (2005). Transforming growth factor (TGF)-beta in conjunction with H-ras activation promotes malignant progression of MCF10A breast epithelial cells. Cytokine, 29, 84-91. DOI ScienceOn
73	Kim, M.S., Lee, E.J., Kim, H.R. and Moon, A. (2003). p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res., 63, 5454-5461.
74	Kim, M.A., Lee, H.S., Lee, H.E., Kim, J.H., Yang, H.K. and Kim, W.H. (2009). Prognostic importance of epithelial-mesenchymal-related protein expression in gastric carcinoma. Histopathology, 54, 442-451. DOI ScienceOn
75	Larue, L. and Bellacosa, A. (2005). Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene, 24, 7443-7454. DOI ScienceOn
76	Lee, M.K., Pardoux, C., Hall, M.C., Lee, P.S., Warburton, D., Qing, J., Smith, S.M. and Derynck, R. (2007). TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J., 26, 3957-3967. DOI ScienceOn
77	Hay, E.D. (1968). Organization and fine structure of epithelium and mesenchyme in the developing chick embryo. In Epithelial-Mesenchymal Interactions; 18th Hahnemann Symposium, (eds. R. Fleischmajer, & R. E. Billingham), Williams & Wilkins, Baltimore.
78	Hay, E.D. (1995). An overview of epithelio-mesenchymal transformation. Acta. Anat., 154, 8-20. DOI
79	Hay, E.D. (2005). The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev. Dyn., 233, 706-720. DOI ScienceOn
80	Cano, A., Pérez-Moreno, M.A., Rodrigo, I., Locascio, A., Blanco, M.J., del Barrio, M.G., Portillo, F. and Nieto, M.A. (2000). The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol., 2, 76-83. DOI ScienceOn
81	Christiansen, J.J. and Rajasekaran, A.K. (2006). Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res., 66, 8319-8326. DOI ScienceOn
82	Christofori, G. (2006). New signals from the invasive front. Nature, 441, 444-450. DOI ScienceOn
83	Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D. and van Roy, F. (2001). The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol. Cell, 7, 1267-1278. DOI ScienceOn
84	Conacci-Sorrell, M., Simcha, I., Ben-Yedidia, T., Blechman, J., Savagner, P. and Ben-Ze’ev, A. (2003). Autoregulation of Ecadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J. Cell Biol., 163, 847-857. DOI ScienceOn
85	Cordon-Cardo, C. and Prives, C. (1999). At the crossroads of inflammation and tumorigenesis. J. Exp. Med., 190, 1367-1370. DOI
86	Davies, M., Robinson, M., Smith, E., Huntley, S., Prime, S. and Paterson, I. (2005). Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J. Cell Biochem., 95, 918-931. DOI ScienceOn
87	Derynck, R. and Zhang, Y.E. (2003). Smad-dependent and Smadindependent pathways in TGF-b family signalling. Nature, 425, 577-584. DOI ScienceOn
88	Huber, M.A., Kraut, N. and Beug, H. (2005). Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr. Opin. Cell. Biol., 17, 548-558. DOI ScienceOn
89	Heldin, C.H., Miyazono, K. and ten Dijke, P. (1997). TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature, 390, 465-471. DOI ScienceOn
90	Hoot, K.E., Lighthall, J., Han, G., Lu, S.L., Li, A., Ju, W., Kulesz-Martin, M., Bottinger, E. and Wang, X.J. (2008). Keratinocytespecific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J. Clin. Invest., 118, 2722-2732.
91	Humar, B., Blair, V., Charlton, A., More, H., Martin, I. and Guilford, P. (2009). E-cadherin deficiency initiates gastric signetring cell carcinoma in mice and man. Cancer Res., 69, 2050-2056. DOI ScienceOn
92	Illman, S.A., Lehti, K., Keski-Oja, J. and Lohi, J.(2006). Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells. J. Cell Sci., 119, 3856-3865. DOI ScienceOn
93	Jones, L.E., Humphreys, M.J., Campbell, F., Neoptolemos, J.P. and Boyd, M.T. (2004). Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. Clin. Cancer Res., 10, 2832-2845. DOI ScienceOn
94	Duong, T.D. and Erickson, C.A. (2004). MMP-2 plays an essential role in producing epithelial-mesenchymal transformations in the avian embryo. Dev. Dyn., 229, 42-53. DOI ScienceOn
95	Feng, X.H. and Derynck, R. (2005). Specificity and versatility in TGF-beta signaling through Smads. Annu. Rev. Cell Dev. Biol., 21, 659-693. DOI ScienceOn
96	Bakin, A.V., Tomlinsos, A.K., Bhowmick, N.A., Moses, H.L. and Arteaga, C.L. (2000). Phosphatidylinositol 3-kinase function is required for transforming growth factor-a-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem., 275, 36803-36810. DOI ScienceOn
97	Adam, L., Zhong, M., Choi, W., Qi, W., Nicoloso, M., Arora, A., Calin, G., Wang, H., Siefker-Radtke, A., McConkey, D., Bar-Eli, M. and Dinney, C. (2009). miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clinical Cancer Research, 15, 5060-5072. DOI ScienceOn
98	Akiyoshi, S., Inoue, H., Hanai, J., Kusanagi, K., Nemoto, N., Miyazono, K. and Kawabata, M. (1999). c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J. Biol. Chem., 274, 35269-35277. DOI ScienceOn
99	Bakin, A.V., Rinehart, C., Tomlinson, A.K. and Arteaga, C.L. (2002). p38 mitogen-activated protein kinase is required for TGFβ-mediated fibroblastic transdifferentiation and cell migration. J.Cell Sci., 115, 3193-3206.
100	Balkwill, F. (2004). Cancer and the chemokine network. Nat. Rev. Cancer, 4, 540-550. DOI ScienceOn
101	Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J. and García De Herreros, A. (2000). The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell. Biol., 2, 84-89. DOI ScienceOn
102	Boyer, B., Valles, A.M. and Edme, N. (2000). Induction and regulation of epithelial-mesenchymal transitions. Biochem. Pharmacol., 60, 1091-1099. DOI ScienceOn
103	Brabletz, T., Hlubek, F., Spaderna, S., Schmalhofer, O., Hiendlmeyer, E., Jung, A. and Kirchner T. (2005). Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin. Cells Tissues Organs, 179, 56-65. DOI ScienceOn

Reference

9	Roxanne H. Croze. (2014) STEM CELLS Translational Medicine ROCK Inhibition Extends Passage of Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium / 3 (9) , 1066
12	Xiaozhong Yang. (2014) Tumor Biology Overexpression of zinc finger E-box binding homeobox factor 1 promotes tumor invasiveness and confers unfavorable prognosis in esophageal squamous cell carcinoma / 35 (12) , 11977
1	Shasha Qi. (2015) Reproductive Biology and Endocrinology Aberrant expression of Notch1/numb/snail signaling, an epithelial mesenchymal transition related pathway, in adenomyosis / 13 (1)
6	Nianshuang Li. (2015) Oncology Reports Role of the LKB1/AMPK pathway in tumor invasion and metastasis of cancer cells (Review) / 34 (6) , 2821
1	(2015) Oncology Reports The natural compound codonolactone attenuates TGF-β1-mediated epithelial-to-mesenchymal transition and motility of breast cancer cells / 35 (1) , 117
3	Yeo-Jung Kwon. (2016) PLOS ONE CYP1B1 Enhances Cell Proliferation and Metastasis through Induction of EMT and Activation of Wnt/β-Catenin Signaling via Sp1 Upregulation / 11 (3) , e0151598
5	(2016) Oncology Reports Rhapontigenin inhibits TGF-β-mediated epithelial-mesenchymal transition via the PI3K/AKT/mTOR pathway and is not associated with HIF-1α degradation / 35 (5) , 2887
1	Mohammed Abba. (2016) Journal of Clinical Medicine MicroRNA Regulation of Epithelial to Mesenchymal Transition / 5 (1) , 8
1	Xu Hou. (2016) Tumor Biology CCL18 promotes the invasion and migration of gastric cancer cells via ERK1/2/NF-κB signaling pathway / 37 (1) , 641
10	Meghna M. Baruah. (2016) Tumor Biology Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases / 37 (10) , 14025
4	Xiaolin Lu. (2016) Toxicology Research MicroRNA-21 activation of Akt via PTEN is involved in the epithelial–mesenchymal transition and malignant transformation of human keratinocytes induced by arsenite / 5 (4) , 1140
6	Geum-A. Lee. (2016) Toxins Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis / 8 (6) , 162
1	(2017) Molecular Cancer Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p / 16 (1)
1	(2017) BMC Ophthalmology Notch1 signaling induces epithelial-mesenchymal transition in lens epithelium cells during hypoxia / 17 (1)
5	Thilo Baronsky. (2017) Nano Letters Cell–Substrate Dynamics of the Epithelial-to-Mesenchymal Transition / 17 (5) , 3320
1643-3750	Li Sheng. (2017) Medical Science Monitor Effect of Slug-Mediated Down-Regulation of E-Cadherin on Invasiveness and Metastasis of Anaplastic Thyroid Cancer Cells / 23 (1643-3750) , 138
7	(2017) Tumor Biology Hook1 inhibits malignancy and epithelial–mesenchymal transition in hepatocellular carcinoma / 39 (7) , 101042831771109
1664-042X	Ben Ke. (2017) Frontiers in Physiology Matrix Metalloproteinases-7 and Kidney Fibrosis / 8 (1664-042X)
1	(2018) International Journal of Molecular Sciences The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review / 19 (1) , 107
1662-8985	(2014) Advanced Materials Research PLK1 Promotes Invasion of Esophageal Squamous Cell Carcinoma Cells through Inducing Epithelial-Mesenchymal Transition / 998-999 (1662-8985) , 279
1	(2018) International Journal of Molecular Sciences Differential Characterization of Temozolomide-Resistant Human Glioma Cells / 19 (1) , 127
12	(2018) Brazilian Journal of Medical and Biological Research MicroRNA-221 promotes cell proliferation, migration, and differentiation by regulation of ZFPM2 in osteoblasts / 51 (12)
12	(2018) Journal of Biological Chemistry The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF–ERK signaling / 293 (12) , 4334
8	(2018) Glia Glioma infiltration and extracellular matrix: key players and modulators / 66 (8) , 1542
2	(2017) Molecular Medicine Reports Targeted inhibition of endoplasmic reticulum stress: New hope for renal fibrosis / 16 (2) , 1014
10	(2017) International Journal of Cancer Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer / 142 (10) , 2028
11	(2018) International Journal of Molecular Sciences Solute Carrier Family 27 Member 4 (SLC27A4) Enhances Cell Growth, Migration, and Invasion in Breast Cancer Cells / 19 (11) , 3434
9	(2018) Journal of Cellular Biochemistry Forkhead-box R2 promotes metastasis and growth by stimulating angiogenesis and activating hedgehog signaling pathway in ovarian cancer / 119 (9) , 7780
1476-5594	(2019) Oncogene The interaction of Lin28A/Rho associated coiled-coil containing protein kinase2 accelerates the malignancy of ovarian cancer / (1476-5594)
18	(2018) Clinical Science / 132 (18) , 2029
10	(2018) Clinical and Translational Oncology Nur77 suppression facilitates androgen deprivation-induced cell invasion of prostate cancer cells mediated by TGF-β signaling / 20 (10) , 1302
1	(2018) Journal of Embryo Transfer The Molecular Basis of Adenomyosis Development / 33 (1) , 49
1	(2019) Scientific Reports Epithelial to Mesenchymal transition, eIF2α phosphorylation and Hsp70 expression enable greater tolerance in A549 cells to TiO2 over ZnO nanoparticles / 9 (1)
2	(2019) Lab on a Chip A scalable filtration method for high throughput screening based on cell deformability / 19 (2) , 343
5	(2018) Cancers The EBV-Encoded Oncoprotein, LMP1, Induces an Epithelial-to-Mesenchymal Transition (EMT) via Its CTAR1 Domain through Integrin-Mediated ERK-MAPK Signalling / 10 (5) , 130
13	(2018) Oncogene TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis / 37 (13) , 1714